Day 1: Top Takeaways From ASCO24

Day 1: Top Takeaways From ASCO24

AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO)AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO)

Up next

Navigating Therapeutic Advances in EGFR-Mutated NSCLC

Dr. Monty Pal and Dr. Vamsi Velcheti discuss the evolving treatment landscape in EGFR-mutated non-small cell lung cancer, including landmark trials like FLAURA2, novel drug therapies, and the growing importance of ctDNA and MRD testing. TRANSCRIPT Dr. Monty Pal: Hello, and welcom ...  Show more

 . 19min 24sec
Highlights From the 2026 ASCO GU Cancers Symposium

Dr. Monty Pal and Dr. Andrea Apolo discuss practice-changing studies and other novel approaches in bladder, kidney, and prostate cancers that were presented at the 2026 ASCO Genitourinary Cancers Symposium. TRANSCRIPT Dr. Monty Pal: Hello and welcome to the ASCO Daily News Podcas ...  Show more

 . 20min 9sec

Recommended Episodes

Review of the GISSI-2 Trial
Cardiology Trials

Lancet 1990;336:65-71.

Background Large trials up to this point had established the role of thr ...

  Show more

 . 10min 3sec
Review of the MIRACL Trial
Cardiology Trials

JAMA 2001;285:1711-18.

Background Statin therapy had been shown to impr ...

  Show more

 . 11min 1sec
363. GLP-1 Agonists: Diving into the Data with Dr. Darren McGuire
Cardionerds: A Cardiology Podcast

Welcome back to the CardioNerds Cardiovascular Prevention Series, where we are continuing our discussion of Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs). This class of medications is becoming a household name, not only for their implications for weight loss but also for ...  Show more

 . 43min 1sec
Podcast 831: O2 Targets
Emergency Medical Minute

Contributor: Aaron Lessen,MD

Educational Pearls:

<ul> <li style="font-weight: 400;" aria-level="1"><span style= "font-weight: 400;">R</span><span style="font-weight: 400;">ecent study looked at mechanically ventilated patients in ED ...  Show more

 . 3min 19sec